Close

TFAP2A

All products and services are For Research Use Only and CANNOT be used in the treatment or diagnosis of disease.

TFAP2A is a transcription factor that binds the consensus sequence 5'-GCCNNNGGC-3'. TFAP2A plays a role as either a homodimer or as a heterodimer with similar family members. TFAP2A activates the transcription of some genes while inhibiting the transcription of others. Defects in this gene can cause branchiooculofacial syndrome (BOFS).
  • CAR Vector Products

  • DMAb

Loading...
  • Target Species:
  • Antibody Clone:
  • Antibody Host:
  • Receptor Construction:
  • Vector Type:
  • Targeting Cell Type:
CAT Product Name Target Species Antibody Clone Antibody Host Receptor Construction Vector Type Targeting Cell Type CAR Vector Type Inquiry & Datasheet
CAR-YJ245 Anti-TFAP2A (2G5) h(41BB-CD3ζ) CAR, pCDCAR1 Human 2G5 Mouse scFv-41BB-CD3ζ Lentiviral vector T cell   Add to Cart   Datasheet
CAR-YJ246 Anti-TFAP2A (A6/2/2) h(41BB-CD3ζ) CAR, pCDCAR1 Human A6/2/2 Mouse scFv-41BB-CD3ζ Lentiviral vector T cell   Add to Cart   Datasheet
CAR-YJ247 Anti-TFAP2A (8C334) h(41BB-CD3ζ) CAR, pCDCAR1 Human, Mouse 8C334 Mouse scFv-41BB-CD3ζ Lentiviral vector T cell   Add to Cart   Datasheet
CAR-YJ248 Anti-TFAP2A (959C2a) h(41BB-CD3ζ) CAR, pCDCAR1 Human, Mouse 959C2a Mouse scFv-41BB-CD3ζ Lentiviral vector T cell   Add to Cart   Datasheet
CAR-YJ745 Anti-TFAP2A (2G5) h(CD28-CD3ζ) CAR, pCDCAR1 Human 2G5 Mouse scFv-CD28-CD3ζ Lentiviral vector T cell   Add to Cart   Datasheet
CAR-YJ746 Anti-TFAP2A (A6/2/2) h(CD28-CD3ζ) CAR, pCDCAR1 Human A6/2/2 Mouse scFv-CD28-CD3ζ Lentiviral vector T cell   Add to Cart   Datasheet
CAR-YJ747 Anti-TFAP2A (8C334) h(CD28-CD3ζ) CAR, pCDCAR1 Human, Mouse 8C334 Mouse scFv-CD28-CD3ζ Lentiviral vector T cell   Add to Cart   Datasheet
CAR-YJ748 Anti-TFAP2A (959C2a) h(CD28-CD3ζ) CAR, pCDCAR1 Human, Mouse 959C2a Mouse scFv-CD28-CD3ζ Lentiviral vector T cell   Add to Cart   Datasheet
Unable to find the desired product? Explore the Filter Options at the top of the list.
Key Updates
Newsletter NEWSLETTER

The latest newsletter to introduce the latest breaking information, our site updates, field and other scientific news, important events, and insights from industry leaders

LEARN MORE NEWSLETTER
New Solution NEW SOLUTION

CellRapeutics™ In Vivo Cell Engineering: One-stop in vivo T/B/NK cell and macrophage engineering services covering vectors construction to function verification.

LEARN MORE SOLUTION
NOVEL SOLUTION NOVEL TECHNOLOGY

Silence™ CAR-T Cell: A novel platform to enhance CAR-T cell immunotherapy by combining RNAi technology to suppress genes that may impede CAR functionality.

LEARN MORE NOVEL TECHNOLOGY
NEW TECHNOLOGY NEW SOLUTION

Canine CAR-T Therapy Development: From early target discovery, CAR design and construction, cell culture, and transfection, to in vitro and in vivo function validation.

LEARN MORE SOLUTION
Receive our latest news and insights.